Brief: Alphameld Corporation Expands Collaboration With Kyowa Kirin For Enterprise-Wide Access To Drug Discovery Platform
28/01/2025 16:05
Jan 28 (Reuters) - Alphameld Corporation:
* ALPHAMELD CORPORATION: CO EXPANDS COLLABORATION WITH KYOWA
KIRIN
FOR ENTERPRISE-WIDE ACCESS TO DRUG DISCOVERY PLATFORM
Source text: ID:nGNX1pn0lc
Further company coverage: 4151.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia